Gossamer Bio, Inc. (GOSS)

USD 0.8

(-7.84%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 4.38 Million 4.42 Million 5.16 Million 4.26 Million 3.08 Million 297 Thousand
Gross Profit -4.38 Million -4.42 Million -5.16 Million -4.26 Million -3.08 Million -297 Thousand
Operating Expenses 183.75 Million 218.52 Million 216.04 Million 210.58 Million 182.53 Million 99.33 Million
Selling, General and Administrative Expenses 38.45 Million 47.6 Million 45.78 Million 49.72 Million 39.13 Million 44.05 Million
Research and Development Expenses 145.3 Million 170.91 Million 170.26 Million 160.85 Million 143.4 Million 55.28 Million
Other Expenses - 1.51 Million 799 Thousand -174 Thousand 5.83 Million 316 Thousand
Cost and Expenses 183.75 Million 218.52 Million 216.04 Million 210.58 Million 182.53 Million 99.33 Million
Operating Income -183.75 Million -218.59 Million -216.12 Million -233.96 Million -186.13 Million -148.99 Million
Interest Expense 13.51 Million 13.88 Million 19.44 Million 12.66 Million - 12 Thousand
Income Tax Expense - 10.85 Million 15.07 Million 8.22 Million 511 Thousand 2.03 Million
Earnings before Tax -179.81 Million -229.37 Million -234 Million -243.36 Million -180.3 Million -146.96 Million
Net Income -179.81 Million -240.22 Million -249.07 Million -251.58 Million -180.81 Million -146.96 Million
Earnings Per Share Basic -1.18 -2.84 -3.33 -3.67 -3.30 -2.43
Earnings Per Share Diluted -1.18 -2.84 -3.33 -3.67 -3.30 -2.43
Weighted Average Shares Outstanding 152.62 Million 84.57 Million 74.84 Million 68.51 Million 54.74 Million 60.4 Million
Weighted Average Shares Outstanding (Diluted) 152.62 Million 84.57 Million 74.84 Million 68.51 Million 54.74 Million 60.4 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -172.15 Million -211.06 Million -209.32 Million -233.96 Million -186.13 Million -148.99 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts